Brainsway
VerifiedBrainsway is the developer of Deep Transcranial Magnetic Stimulation (TMS) Therapy, a patented, noninvasive, FDA-cleared solution for treating depressive episodes in adult patients suffering from major depressive disorder who have failed to achieve s.
Launch date
Employees
Market cap
$91.2m
Net debt
$45.5m
Enterprise valuation
$46m (Public information from May 2024)
Share price
$6.29 BWAY
Burlington Massachusetts (HQ)